|
Antibiotics prescribed for ventilator-associated tracheobronchitis episodes |
|
| n = 22 |
|
|
|
|
| Aminoglycosides |
10 (45) |
| Imipenem |
9 (40) |
| Ciprofloxacin |
5 (22) |
| Piperacillin/tazobactam |
5 (22) |
| Ceftazidime |
1 (4) |
| Ticarcillin/clavulanate |
1 (4) |
| Amoxicillin/clavulanate |
1 (4) |
| Methicillin |
1 (4) |
| Ceftriaxone |
1 (4) |
| Vancomycin |
1 (4) |
| Rifampin |
1 (4) |
| Colimycin |
1 (4) |
| Tigecycline |
1 (4) |
| Combination therapy |
16 (72) |
| β-lactams and aminoglycosides |
9 (40) |
| β-lactams and ciprofloxacin |
5 (22) |
| Vancomycin and aminoglycoside |
1 (4) |
| Colimycin and rifampin |
1 (4) |
|
Results are presented as number (percentage). Monotherapy was given to patients with ventilator-associated tracheobronchitis related to methicillin-sensitive Staphylococcus aureus (n = 2), Escherichia coli (n = 2), Streptococcus pneumoniae (n = 1), and methicillin-resistant S. aureus (n = 1). | |
Nseir et al. Critical Care 2008 12:R62 doi:10.1186/cc6890 |
|